Mandibular Overdenture Retained by 1 or 2 Implants: a Cost-effectiveness Analysis
赞助:
Universidade Federal de Goias
合作者:
信息的提供 (责任方):
Cláudio Rodrigues Leles,Universidade Federal de Goias
追踪信息 | |||
---|---|---|---|
首次提交日期 ICMJE | September 28, 2018 | ||
首次发布日期e ICMJE | October 1, 2018 | ||
最后更新发布日期 | October 2, 2018 | ||
预计研究开始日期 ICMJE | April 9, 2017 | ||
预计主要完成日期 | February 9, 2019 (主要结果测量的最终数据收集日期) | ||
目前主要观察指标 ICMJE |
Satisfaction with the dentures[ Time Frame: Changes from baseline to 12 months after the intervention ] A 100 cm graduated visual analogue scale will be used in order to assess the participants' ratings of their satisfaction with the upper and lower dentures in relation to the parameters "general satisfaction", "comfort", "stability", "aesthetics", "ability to speak" and "ability to chew". Each participant will indicate their level of satisfaction with each parameter by marking a point along the scale, in which ends mean "unsatisfied" and "satisfied", as it is closer to the beginning or the end of the scale, respectively. |
||
原始主要观察测量 ICMJE | 与当前相同 | ||
目前的二级观察 ICMJE |
|
||
描述性信息 | |||
简略标题 ICMJE | Mandibular Overdenture Retained by 1 or 2 Implants: a Cost-effectiveness Analysis | ||
正式标题 ICMJE | Mandibular Overdenture Retained by 1 or 2 Implants: a Cost-effectiveness Analysis | ||
简要概况 | The aim of this study is to assess the cost-effectiveness of the mandibular overdenture retained by one and two implants, based on a randomized clinical trial. |
||
详细说明 | This randomized clinical trial alongside a cost-effectiveness analysis will include 48 edentulous individuals who meet eligibility criteria. New maxillary and mandibular dentures will be fabricated for all participants following a standardized protocol. Then, participants will be randomized into one of the treatment groups: mandibular overdenture retained by two implants group or single-implant mandibular overdenture group. Each participant allocated to the single-implant mandibular overdenture group will then receive a Straumann® Standard Plus SLActive® regular neck implant (Straumann 0.33.051S/052S/053S Institute Straumann AG, Basel, Switzerland) in the mandibular midline, and the mandibular overdenture retained by two implants group will receive two implants of the same specification, in the interphoramen region. A healing abutment will be connected and the implant will be allowed to heal for approximately 3 weeks. Then, a 3.4mm retentive titanium anchor abutment (Straumann 048.439, Institute Straumann AG, Basel, Switzerland) will be connected and tightened to 35 N.cm with a torque wrench. The matrix will be incorporated to the denture using self-curing acrylic resin and the patient will be instructed to keep the upper and lower dentures firmly occluded in the habitual position until the final polymerization of the resin. Outcomes (satisfaction with the dentures and oral health-related quality of life) will be measured at baseline and at the 6- and 12-month follow-up. Direct costs related to therapies in both groups will be identified, measured and valuated for one year after treatment. Incremental cost-effectiveness ratios will be estimated and graphically presented on cost-effectiveness planes. Sensitivity analysis on the most important assumptions will be performed in order to assess the robustness of the model. | ||
研究类型 ICMJE | Interventional | ||
研究阶段 | N/A | ||
研究设计 ICMJE | 分配: Randomized 干预模型: Parallel Assignment 干预模型描述: Comparative effectiveness of two competing strategies for the edentulous mandible using implants 盲法: Interventional 盲法描述:To avoid selection bias and ensure adequate allocation concealment, their treatment group will only be revealed for each participant after the assessment of the baseline outcomes, which will occur after the delivery and regular use of the new set of conventional dentures. Since full blinding for the two interventions is not possible for those involved with treatment management and collection of data, only those collecting and analyzing clinical data from masticatory performance tests will be unaware of the assigned treatment. 主要目的: Treatment |
||
适用条件 ICMJE | |||
干预项目 ICMJE |
|
||
研究工具 |
|
||
招募信息 | |||
招募状态 ICMJE | Recruiting | ||
预计入组 ICMJE |
48 | ||
原始预计入组 ICMJE | 与当前相同 | ||
预计研究完成日期 | July 23, 2019 | ||
预计主要完成日期 | February 9, 2019 (主要结果测量的最终数据收集日期) | ||
合格标准 ICMJE | Inclusion Criteria: - No contraindications for implant surgery (mainly related to uncontrolled systemic diseases) - Present enough bone volume in the mandibular midline area for implant placement without the need of bone augmentation procedures. - Be able to understand and answer the questionnaires used in the study - Agree to participate by providing a written informed consent. Exclusion Criteria: - Noncompliant participants - Individuals who do not agree to be randomly allocated to the treatment study group - Presence of signs of untreated temporomandibular disorders, uncontrolled systemic or oral conditions that require additional treatments | ||
性别 |
|
||
年龄 | 最小年龄:N/A ,最大年龄:N/A | ||
接受健康的志愿者 | 没有 | ||
可入组国家 ICMJE | Brazil | ||
管理信息 | 数据检测委员会 | Yes | |
研究涉及美国FDA监管的产品 |
研究美国FDA监管的药品: No 研究涉及美国FDA监管的设备产品: No |
||
IPD 共享声明 |
|
||
责任方 | Cláudio Rodrigues Leles,Universidade Federal de Goias | ||
研究赞助商 ICMJE | Universidade Federal de Goias | ||
合作者 ICMJE | |||
研究员 ICMJE |
|
||
PRS 账户 | Universidade Federal de Goias | ||
验证日期 | September 2018 | ||
ICMJE 国际医学期刊编辑委员会和 世界卫生组织 ICTRP 要求的元素 |
请使用微信扫码报名